Marathi
|
Hindi
Download App
Epaper
Home
City
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Chhatrapati Sambhajinagar
Nagpur
Entertainment
Photos
Business
Technology
Sports
Lifestyle
Social Viral
Lokmat Games
Health
City
Home
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Nagpur
Chhatrapati Sambhajinagar
Trending Topics :
Lok Sabha Election 2024
Heatwave In India
Mumbai Water Cut
Maharashtra Lok Sabha Election
IPL 2024
Salman Khan
All
News
Photos
Videos
Mylan
FOLLOW
Mylan, Latest News
Mylan N.V. is a global generic and specialty pharmaceuticals company registered in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and a "Global Center" in Canonsburg, Pennsylvania, US.
Read More
Aurangabad :
Smart buses on the road again from today
Ex-serviceman appointed as driver, conductors Aurangabad, Jan 22: The city bus service has been closed for the last 77 ... ...
Aurangabad :
AMC gives 1000 Remdesivir injections to private hospitals
Aurangabad, April 18: The Aurangabad Municipal Corporation (AMC) gave 1000 ‘Remdesivir’ injections to private hospitals of the city on ... ...
International :
COVID-19: 3 Indian companies start supply of life-saving Remdesivir to Nepal
Three Indian pharmaceutical companies have started supplying Nepal with life-saving anti-viral Remdesivir to be used for the treatment of COVID-19 patients. ...
Health :
Mylan launches remdesivir supply in India under 'DESREM' name
Bengaluru, July 20 Global pharmaceutical company Mylan on Monday announced the commercial launch of the generic version of ... ...
National :
Mylan announces commercial launch of its Remdesivir under brand name DESREMTM in India
Pharmaceutical company Mylan on Monday announced the commercial launch of its Remdesivir under the brand name DESREMTM in India to address urgent, unmet needs amid COVID-19 pandemic. ...
Business :
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per vial
Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI) and will launch a generic version of Gilead Sciences' COVID-19 anti-viral in the country at Rs 4,800 for 100 mg/vial. ...
National :
DCGI gives nod to Mylan labs to manufacture remdesivir for 'restricted emergency use' on COVID-19 patients
The Drug Controller General of India (DCGI) has granted permission to Mylan laboratories to manufacture and market the anti-viral drug remdesivir for 'restricted emergency use' on hospitalised COVID-19 patients, a senior government official said on T ...
National :
Biocon's diabetes drug available under PBS in Australia
Biotech major Biocon said here on Thursday its insulin Glargine Semglee, co-developed with Mylan to treat diabetes, was available in Australia under the pharmaceutical benefits scheme (PBS). ...